NIAID grant supports research aimed at improving outcomes for patients with Aspergillus infections

Aspergillus fumigatus is the major airborne fungus present indoors and outdoors that causes various diseases, the severity of which are dependent on an individual’s immune status.

Evolva informs about renegotiation of financing arrangement, initiates review of strategic alternatives and revokes guidance – Biotech Investments

Evolva Holding SA / Key word(s): Strategic Company Decision 14-Jun-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The

June 15, 2023

Getting CRISPR treatments to patients remains a major challenge. Could lab-developed tests help?

CRISPR is no longer a promising but unproven technology — it is a reality. But for this powerful gene-editing tool to reach its full potential,

March 21, 2024

MGI Reveals Latest Updates at ESHG Conference in Glasgow

MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technology to lead life science, held a Corporate Satellite Meeting and revealed

June 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.